Related Experiment Video
Updated: Aug 24, 2025
07:04
Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology
Published on: January 24, 2025
529
Haemolytic uraemic syndrome
Mini Michael1, Arvind Bagga2, Sarah E Sartain3
1Division of Pediatric Nephrology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Lancet (London, England)
|October 22, 2022
Summary
Haemolytic uraemic syndrome (HUS) is a complex condition involving thrombotic microangiopathy. Identifying the specific cause is crucial for personalized treatment, especially for complement-mediated HUS, though therapies remain inaccessible in low-income regions.
Area of Science:
- Nephrology
- Hematology
- Pathology
Background:
- Haemolytic uraemic syndrome (HUS) is a group of diseases characterized by thrombotic microangiopathy, presenting as hemolytic anemia, thrombocytopenia, and acute kidney injury.
- Shiga toxin-producing Escherichia coli (STEC) is the most common cause of HUS.
- Accurate diagnosis of the underlying trigger for thrombotic microangiopathy is essential for effective patient management.
Purpose of the Study:
- To review the diverse causes of HUS.
- To highlight the importance of identifying specific HUS triggers for targeted therapies.
- To discuss the impact of novel treatments, such as anti-complement therapies, on patient outcomes.
Main Methods:
- Review of current literature on HUS.
- Discussion of different etiological categories of HUS.
- Analysis of treatment strategies and outcomes for various HUS subtypes.
Main Results:
- Complement-mediated HUS, previously associated with high mortality, now shows excellent outcomes with anti-complement therapies.
- The high cost of anti-complement therapies limits their accessibility in low-income countries.
- Targeted therapies for many other forms of HUS are still under development.
Conclusions:
- Personalized treatment based on the specific HUS trigger significantly improves patient outcomes.
- While effective therapies exist for some HUS forms, accessibility and development of treatments for other types remain challenges.
- Further research is needed to identify and develop targeted therapies for the broader spectrum of HUS causes.
Related Concept Videos
01:24Hemodialysis II: Procedure and Complications
101
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
101
01:24Nephrotic Syndrome I : Introduction
18
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
18
01:25Hemodialysis I: Introduction
216
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
216
01:25Urinary Tract Infection II: Pathophysiology
31
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
31
01:23Rheumatic Heart Disease I: Introduction
31
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
01:26Nephrotic Syndrome II : Assessment and Medical Management
16
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16